Skip to content
★ Sign in to follow
NIOX Group plc logo

NIOX Group plc Stock: price and insider trades · United Kingdom

ISIN GB00BJVD3B28GB·Mcap £290.4MHealth Care

No insider purchase over the last 90 days. The latest, by Sarah Duncan, was filed 01 Jun 2026.

NIOX Group plc: what insiders have been doing

This page follows insider dealings at NIOX Group plc as filed with RNS (LSE), a company from the Health Care sector. The last twelve months, up to 23 October 2026, brought 8 filings signed by 4 insiders.

Purchases and sales both appear in the filings: 6 purchases (4 insiders, €212k) and 1 sale (1 insider, €23k). On balance, insiders were net buyers of €189k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Jonathan Emms filed the largest purchase, €69k, on 21 April 2026. Among those who bought: 2 board members, 1 finance chief and 1 chief executive.

Across the 833 companies tracked on its exchange, the median is 6 filings; at 8 filings, this issuer sits above that mark. Our records for NIOX Group plc go back to 2024, with 10 purchases and 5 sales on the open market in total.

The data flag 5 purchases as part of a group of insiders buying within 30 days of each other. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. The last insider purchase was made public on 1 June 2026, 160 days ago. Between a trade and the moment it shows up on RNS (LSE), the median delay is 1 day. The regulation allows three business days to notify a trade (UK MAR).

Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and EssilorLuxottica. Every figure here comes from the filings published by RNS (LSE) and describes the past, not future prices; it is not investment advice.

Insider Decl.
21
Thresholds
n/a
Buy Volume
€354,112
10 ops. · all time
Sell Volume
€68,737
5 ops. · all time

Who traded when

BuySale
Sarah Duncan3 buys1 sale
Jonathan Emms2 buys
Sharon Emms2 buys
James Duncan1 buy

Since the insiders bought

  • Filed 01 Jun 2026 · 160 days ago · €46k
    +11.5%
    Entry £0.61 · Close at T+90 £0.68
  • Filed 29 May 2026 · 162 days ago · €23k
    +17.2%
    Entry £0.58 · Close 16 Oct 2026 £0.68
  • Filed 21 Apr 2026 · 201 days ago · €69k
    -4.3%
    Entry £0.65 · Close at T+90 £0.62

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Analyst consensus: bullish or bearish?

Analysts rate NIOX Group plc Strong Buy (bullish), based on 5 analysts. Average price target: £0.82.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 7,406 of 26,897 companies
62.8
score / 100
Value
45
Quality
81
FCF yld4.8%
Earn yld2.4%
EV/EBITDA19.0x
ROE11%
Gross mgn69%
Net mgn14%
Debt/EBITDA0.1x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

£0.69
Analyst consensus
5 analysts
Strong buy
£0.77Target £0.82(+19%)£0.86
Income statement
Revenue£48.7M
Gross profit£33.7M69% margin
EBITDA£15.3M31% margin
Net income£7M14.7% margin
Valuation
PER (trailing)34.5x
PER (forward)1958.0x
P/Book436.7x
Beta-0.04
Balance sheet & cash
Market cap£290.4M
Total debt£1M
Free Cash Flow£13.9M
Debt / Equity1%
Profitability & ownership
ROE10.7%
ROA9.0%
% insiders20.9%
% institutions64.9%
Last declaration on 1 June 2026
Declarations21 total
  • ▲
    Chief Financial OfficerExecutives
    39,955 GBP35RNS
    68,358 shares@ £0.58450.016% mcap38.5% of flowLondon Stock Exchange, AIMISIN GB00BJVD3B28RNS:9592854-0
    Canonical exit: 26 Aug 2026 (T+90)
  • ▼
    Chief Financial OfficerExecutives
    20,010 GBP21RNS
    33,916 shares@ £0.5919.3% of flowLondon Stock Exchange, AIMISIN GB00BJVD3B28RNS:895d59fc-4e2a-419d-8d21-c2ffcb5bc9ce-1
  • ▲
    PCA of Sarah Duncan, Chief Financial OfficerExecutives
    19,998 GBP27RNS
    34,127 shares@ £0.586100.0% of flowLondon Stock Exchange, AIMISIN GB00BJVD3B28RNS:895d59fc-4e2a-419d-8d21-c2ffcb5bc9ce-2
    Canonical exit: 27 Aug 2026 (T+90)
  • ▲
    Chief Financial OfficerExecutives
    39,989 GBP35RNS
    68,358 shares@ £0.58538.5% of flowLondon Stock Exchange, AIMISIN GB00BJVD3B28RNS:895d59fc-4e2a-419d-8d21-c2ffcb5bc9ce-0
    Canonical exit: 26 Aug 2026 (T+90)
  • ▲
    Chief Executive OfficerExecutives
    60,237 GBP38RNS
    104,036 shares@ £0.57936.7% of flowLondon Stock Exchange, AIMISIN GB00BJVD3B28RNS:cee71e2c-05e3-49c0-b759-392a571646b3-0
    Canonical exit: 19 Jul 2026 (T+90)
  • ▲
    PCA of Jonathan Emms, Chief Executive OfficerExecutives
    19,991 GBP24RNS
    34,539 shares@ £0.578848.7% of flowLondon Stock Exchange, AIMISIN GB00BJVD3B28RNS:cee71e2c-05e3-49c0-b759-392a571646b3-1
    Canonical exit: 19 Jul 2026 (T+90)
  • ◆
    Chief Executive OfficerExecutives
    108 GBP22RNS
    135,188 shares@ £0.00080.1% of flowLondon Stock Exchange, AIMISIN GB00BJVD3B28RNS:8b743779-f790-403d-8426-6404bd239380
  • ▲
    Chief Financial OfficerExecutives
    3,901 GBP19RNS
    5,522 shares@ £0.70643.7% of flowLondon Stock ExchangeISIN GB00BJVD3B28RNS:f256150f-cb69-4ac6-bcfe-ae4f0eb6d3d8
    Canonical exit: 3 Mar 2026 (T+90)
  • ◆
    Non-Executive ChairmanExecutives
    116 GBP15RNS
    144,844 shares@ £0.0008100.0% of flowLondon Stock Exchange, AIMISIN GB00BJVD3B28RNS:5713752
  • ◆
    1. Executive Chairman 2. Chief Executive Officer 3. Chief Financial OfficerExecutives
    0RNS
    0London Stock Exchange, AIMISIN GB00BJVD3B28RNS:5597657
  • ▲
    Chief Operating OfficerExecutives
    59,755 GBP27RNS
    94,489 shares@ £0.632438.4% of flowLondon Stock Exchange, AIMISIN GB00BJVD3B28RNS:5474047-0
    Canonical exit: 18 Mar 2025 (T+90)
  • ▲
    PCA of Jonathan Emms, Chief Operating OfficerExecutives
    19,986 GBP24RNS
    31,604 shares@ £0.632451.3% of flowLondon Stock Exchange, AIMISIN GB00BJVD3B28RNS:5474047-1
    Canonical exit: 18 Mar 2025 (T+90)
  • ●
    Chief Financial OfficerExecutives
    0RNS
    88,490 sharesOff marketISIN GB00BJVD3B28RNS:5214281
  • ▼
    Chief Financial OfficerExecutives
    19,125 GBP36RNS
    30,000 shares@ £0.637550.0% of flowLondon Stock Exchange, AIMISIN GB00BJVD3B28RNS:5132347-0
  • ▲
    Chief Financial OfficerExecutives
    19,155 GBP0RNS
    30,000 shares@ £0.638550.0% of flowLondon Stock Exchange, AIMISIN GB00BJVD3B28RNS:5132347-1
    Canonical exit: 4 Jul 2024 (T+90)
  • ▼
    Chief Operating OfficerExecutives
    20,000 GBP12RNS
    31,250 shares@ £0.6412.4% of flowLondon Stock Exchange, AIMISIN GB00BJVD3B28RNS:5128623-0
  • ▲
    Chief Operating OfficerExecutives
    20,000 GBP0RNS
    31,007 shares@ £0.64512.4% of flowLondon Stock Exchange, AIMISIN GB00BJVD3B28RNS:5128623-1
    Canonical exit: 2 Jul 2024 (T+90)
  • ◆
    1. Executive Chairman 2. Chief Operating Officer 3. Chief Financial OfficerExecutives
    0RNS
    0London Stock Exchange, AIMISIN GB00BJVD3B28RNS:5126622-0
  • ▼
    1. Executive Chairman 2. Chief Operating Officer 3. Chief Financial OfficerExecutives
    0RNS
    0London Stock Exchange, AIMISIN GB00BJVD3B28RNS:5126622-1
  • ◆
    1. Executive Chairman 2. Chief Operating Officer 3. Chief Financial OfficerExecutives
    0RNS
    0London Stock Exchange, AIMISIN GB00BJVD3B28RNS:5124426-0
  • ▼
    1. Executive Chairman 2. Chief Operating Officer 3. Chief Financial OfficerExecutives
    0RNS
    0London Stock Exchange, AIMISIN GB00BJVD3B28RNS:5124426-1

21 of 21 declarations

About NIOX Group plc

NIOX Group plc is a company focused on the development and commercialization of medical devices for the diagnosis and management of asthma. It is listed on the London Stock Exchange.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations